These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Limitation of vWf meta-analysis in LMWH comparison. Hödl R; Huber K; Kraxner W; Klein W J Am Coll Cardiol; 2001 Jun; 37(7):2006-7. PubMed ID: 11401147 [No Abstract] [Full Text] [Related]
44. NICE recommends greater use of thrombolytics in acute myocardial infarction. Mayor S; BMJ; 2002 Nov; 325(7372):1057. PubMed ID: 12428607 [No Abstract] [Full Text] [Related]
45. [Unfractionated heparin and low molecular weight heparin for acute coronary syndromes--assessment of a Cochrane review]. Husted SE; Nielsen HK Ugeskr Laeger; 2010 Oct; 172(42):2888-91. PubMed ID: 21040659 [TBL] [Abstract][Full Text] [Related]
46. [The role of low-molecular-weight heparin in unstable angina, acute myocardial infarction and post-elective percutaneous transluminal coronary angioplasty]. Pimentel Filho WA Arq Bras Cardiol; 1995 Dec; 65(6):517-8. PubMed ID: 8731307 [No Abstract] [Full Text] [Related]
47. Evolving role of low-molecular-weight heparins in ST-elevation myocardial infarction. Kalus JS; Moser LR Ann Pharmacother; 2005 Mar; 39(3):481-91. PubMed ID: 15701782 [TBL] [Abstract][Full Text] [Related]
48. Low-molecular-weight heparins for the treatment of acute coronary syndromes. Wong GC; Giugliano RP Semin Vasc Med; 2003 Nov; 3(4):391-402. PubMed ID: 15199446 [TBL] [Abstract][Full Text] [Related]
49. LMWH in acute myocardial infarction. Dutta AL Indian Heart J; 2011; 63(1):84-8. PubMed ID: 23189870 [No Abstract] [Full Text] [Related]